Drug Shortages Back In US Congressional Spotlight
Executive Summary
Drug shortages were a significant focus of legislative attention in the US before the COVID-19 pandemic, and Congress is not likely to drop the issue now that the public health emergency is winding down.
You may also be interested in...
Public-Private Consortium To Strengthen Essential Medicines Supply Under White House Initiative
President Biden’s 100-day plan relies on Defense Production Act authorities to increase resilience of critical domestic pharmaceutical supplies.
Initial List Of US Essential Medicines Focuses On Acute Care
US FDA excludes chronic care products from list of medicines bolstered by domestic production investment and federal procurement requirements.
Real-Time Manufacturing Volume Reporting Could Help Prevent Drug Shortages, Woodcock Tells Congress
If the US FDA could track production, it could anticipate shortages – and national security threats from countries like China.